Healthcare provider profile · identity verified

Dallis Mark Bowditch, M.D.

Family Practice · LOGANSPORT, IN · NPI 1790788255

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	833	39
Pantoprazole Sodium	Pantoprazole Sodium	702	36
Levothyroxine Sodium	Levothyroxine Sodium	671	29
Furosemide	Furosemide	663	49
Escitalopram Oxalate	Escitalopram Oxalate	631	26
Gabapentin	Gabapentin	531	24
Potassium Chloride	Potassium Chloride	449	28
Lisinopril	Lisinopril	446	17
Spironolactone	Spironolactone	440	28
Metoprolol Succinate	Metoprolol Succinate	435	20
Donepezil Hcl	Donepezil Hcl	425	14
Eliquis	Apixaban	402	27
Sertraline Hcl	Sertraline Hcl	350	14
Tamsulosin Hcl	Tamsulosin Hcl	343	19
Amlodipine Besylate	Amlodipine Besylate	333	24
Famotidine	Famotidine	305	15
Buspirone Hcl	Buspirone Hcl	287	14
Mirtazapine	Mirtazapine	282	13
Carvedilol	Carvedilol	265	14
Memantine Hcl	Memantine Hcl	257	suppressed
Clopidogrel	Clopidogrel Bisulfate	253	14
Metoprolol Tartrate	Metoprolol Tartrate	244	16
Metformin Hcl	Metformin Hcl	214	suppressed
Chlorthalidone	Chlorthalidone	213	suppressed
Allopurinol	Allopurinol	202	13
Carbidopa-Levodopa	Carbidopa/Levodopa	193	suppressed
Hydralazine Hcl	Hydralazine Hcl	176	suppressed
Trazodone Hcl	Trazodone Hcl	170	suppressed
Lorazepam	Lorazepam	166	16
Tramadol Hcl	Tramadol Hcl	161	suppressed
Trintellix	Vortioxetine Hydrobromide	152	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	147	13
Duloxetine Hcl	Duloxetine Hcl	132	suppressed
Omeprazole	Omeprazole	132	suppressed
Finasteride	Finasteride	125	suppressed
Losartan Potassium	Losartan Potassium	122	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	122	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	119	suppressed
Paroxetine Hcl	Paroxetine Hcl	115	suppressed
Tizanidine Hcl	Tizanidine Hcl	114	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	110	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	109	52
Baclofen	Baclofen	108	suppressed
Pravastatin Sodium	Pravastatin Sodium	108	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	106	suppressed
Torsemide	Torsemide	99	suppressed
Entresto	Sacubitril/Valsartan	91	suppressed
Farxiga	Dapagliflozin Propanediol	90	suppressed
Tradjenta	Linagliptin	89	suppressed
Divalproex Sodium	Divalproex Sodium	88	suppressed
Primidone	Primidone	84	suppressed
Meloxicam	Meloxicam	83	suppressed
Loperamide	Loperamide Hcl	79	28
Myrbetriq	Mirabegron	79	suppressed
Pregabalin	Pregabalin	74	suppressed
Fentanyl	Fentanyl	71	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	71	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	71	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	71	suppressed
Warfarin Sodium	Warfarin Sodium	71	suppressed
Clonidine Hcl	Clonidine Hcl	70	suppressed
Lamotrigine	Lamotrigine	68	suppressed
Ropinirole Hcl	Ropinirole Hcl	65	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	64	23
Levetiracetam	Levetiracetam	63	suppressed
Insulin Lispro	Insulin Lispro	60	13
Glipizide Er	Glipizide	58	suppressed
Citalopram Hbr	Citalopram Hydrobromide	57	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	56	suppressed
Metolazone	Metolazone	56	suppressed
Prednisone	Prednisone	55	suppressed
Propranolol Hcl	Propranolol Hcl	55	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	54	suppressed
Celecoxib	Celecoxib	53	suppressed
Colestipol Hcl	Colestipol Hcl	53	suppressed
Labetalol Hcl	Labetalol Hcl	53	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	53	suppressed
Colchicine	Colchicine	52	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	52	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	52	suppressed
Calcitriol	Calcitriol	51	suppressed
Digoxin	Digoxin	51	suppressed
Folic Acid	Folic Acid	50	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	49	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	47	suppressed
Carbamazepine Er	Carbamazepine	46	suppressed
Memantine Hcl Er	Memantine Hcl	46	suppressed
Clonazepam	Clonazepam	44	suppressed
Alendronate Sodium	Alendronate Sodium	42	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	41	suppressed
Probenecid	Probenecid	41	suppressed
Cilostazol	Cilostazol	40	suppressed
Breo Ellipta	Fluticasone/Vilanterol	37	suppressed
Ceftriaxone	Ceftriaxone Sodium	37	11
Fluoxetine Hcl	Fluoxetine Hcl	37	suppressed
Lagevrio (Eua)	Molnupiravir	37	34
Ondansetron Hcl	Ondansetron Hcl	37	17
Doxazosin Mesylate	Doxazosin Mesylate	36	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	36	suppressed
Alprazolam	Alprazolam	33	suppressed
Cephalexin	Cephalexin	33	suppressed
Risperidone	Risperidone	32	suppressed
Montelukast Sodium	Montelukast Sodium	31	suppressed
Nuedexta	Dextromethorphan Hbr/Quinidine	30	suppressed
Simvastatin	Simvastatin	30	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	28	suppressed
Fluvoxamine Maleate	Fluvoxamine Maleate	28	suppressed
Azithromycin	Azithromycin	27	12
Fluticasone Propionate	Fluticasone Propionate	27	suppressed
Nystatin	Nystatin	27	18
Fiasp	Insulin Aspart (Niacinamide)	26	suppressed
Lacosamide	Lacosamide	26	suppressed
Roflumilast	Roflumilast	26	suppressed
Amantadine	Amantadine Hcl	25	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	25	suppressed
Meclizine Hcl	Meclizine Hcl	25	suppressed
Oxycodone Hcl	Oxycodone Hcl	25	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	25	suppressed
Sucralfate	Sucralfate	25	suppressed
Bupropion Xl	Bupropion Hcl	24	suppressed
Latanoprost	Latanoprost	24	suppressed
Scopolamine	Scopolamine	24	suppressed
Zenpep	Lipase/Protease/Amylase	23	suppressed
Dapagliflozin	Dapagliflozin Propanediol	22	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	22	suppressed
Terazosin Hcl	Terazosin Hcl	22	suppressed
Gemtesa	Vibegron	20	suppressed
Tresiba Flextouch U-200	Insulin Degludec	20	suppressed
Budesonide	Budesonide	19	suppressed
Mounjaro	Tirzepatide	19	suppressed
Semglee (Yfgn)	Insulin Glargine-Yfgn	19	suppressed
Trulicity	Dulaglutide	18	suppressed
Aranesp	Darbepoetin Alfa In Polysorbat	17	suppressed
Bupropion Hcl Sr	Bupropion Hcl	17	suppressed
Dutasteride	Dutasteride	17	suppressed
Lidocaine Hcl	Lidocaine Hcl	17	suppressed
Metformin Er Gastric	Metformin Hcl	17	suppressed
Aptiom	Eslicarbazepine Acetate	16	suppressed
Glimepiride	Glimepiride	16	suppressed
Glipizide	Glipizide	16	suppressed
Hydrocortisone	Hydrocortisone	14	suppressed
Ventolin Hfa	Albuterol Sulfate	14	suppressed
Acetazolamide	Acetazolamide	13	suppressed
Amiodarone Hcl	Amiodarone Hcl	13	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	13	suppressed
Diltiazem Hcl	Diltiazem Hcl	13	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	13	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	13	suppressed
Fycompa	Perampanel	12	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	12	suppressed
Meropenem	Meropenem	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error